Stem Cells

Comprehensive Biotechnology, Second Edition

Volumn 1, Issue , 2011, Pages 341-365

  Oh, S K W ^a   Choo, A B H ^a  

^a AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85012827358     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-088504-9.00038-6     Document Type: Chapter

References (190)

1. Aboody K.S., Brown A., Rainov N.G., et al. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proceedings of the National Academy of Sciences 2000, 97:12846-12857.
2. Adewumi O., Aflatoonian B., Ahrlund-Richter L., et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nature Biotechnology 2007, 25:803-816.
3. Azuara V., Perry P., Sauer S., et al. Chromatin signatures of pluripotent cell lines. Nature Cell Biology 2006, 8:532-538.
4. Barberi T., Willis L.M., Socci N.D., Studer L. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Medicine 2005, 2:161. -161.
5. Barry F.P., Murphy J.M. Mesenchymal stem cells: Clinical applications and biological characterization. International Journal of Biochemistry and Cell Biology 2004, 36:568-584.
6. Baum C.M., Weissman I.L., Tsukamoto A.S., et al. Isolation of a candidate human hematopoietic stem cell population. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:2804-2808.
7. Becker A.J., McCulloch E.A., Till J.E. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 1963, 197:452-454.
8. Campagnoli C., Roberts I.A., Kumar S., et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001, 98:2396-2402.
9. Caplan A.L. The mesengenic process. Clinics in Plastic Surgery 1994, 21:429-435.
10. Charbord P., Tavian M., Humeau L., Peault B. Early ontogeny of the human marrow from long bones: An immunohistochemical study of hematopoiesis and its microenvironment. Blood 1996, 87:4109-4119.
11. Chung Y., Klimanskaya I., Becker S., et al. Human embryonic stem cell lines generated without embryo destruction. Cell Stem Cell 2007, 2:113-117.
12. Copelan E.A. Hematopoietic stem-cell transplantation. New England Journal of Medicine 2006, 354:1813-1826.
13. Crisan M., Yap S., Casteilla L., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3:301-313.
14. Da Silva M.L., Caplan A.L., Nardi N.B. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008, 26:2287-2299.
15. De Bari C., Dell' Accio F., Tylzanowski P., Luyten F.P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis and Rheumatism 2001, 44:1928-1942.
16. Deleyrolle L., Reynolds B.A. Isolation, expansion, and differentiation of adult mammalian neural stem and progenitor cells using the neurosphere assay. Methods in Molecular Biology 2009, 549:91-101.
17. Digirolamo C.M., Stokes D., Colter D., et al. Propagation and senescence of human marrow stromal cells in culture: A simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. British Journal of Haematology 1999, 107:275-281.
18. Ehtesham M., Yuan X., Kabos P., et al. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia 2004, 6:287-293.
19. Erices A., Conget P., Minguell J.J. Mesenchymal progenitor cells in human umbilical cord blood. British Journal of Haematology 2000, 109:235-242.
20. Feng Q., Lu S.J., Klimanskaya I., et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 2010, 28:704-712.
21. Flax J.D., Aurora S., Yang C., et al. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nature Biotechnology 1998, 16:1033-1039.
22. Gage F.H., Ray J., Fisher L.J. Isolation, characterization, and use of stem cells from the CNS. Annual Review of Neuroscience 1995, 18:159-192.
23. Galy A., Travis M., Cen D., Chen B. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 1995, 3:459-473.
24. Gatti R.A., Meuwissen H.J., Allen H.D., et al. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968, 2:1366-1369.
25. Gluckman E., Broxmeyer H.A., Auerbach A.D. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. New England Journal of Medicine 1989, 321:1174-1178.
26. Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Experimental Hematology 2000, 28:1197-1205.
27. Grigoriadis A.E., Kennedy M., Bozec A., et al. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood 2010, 115(14):2769-2776. Epub 2010 Jan 11.
28. Hua L., Zhaohui, Yonghak K., Saul S., Yoon-Young J. Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology 2010, 51:1810-1819.
29. Jankowski R.J., Deasy B.M., Huard J. Muscle-derived stem cells. Gene Therapy 2002, 9:642-647.
30. Johansson C.B., Momma S., Clarke D.L., et al. Identification of a neural stem cell in the adult mammalian central nervous system. Cell 1999, 96:25-34.
31. Kebriaei P., Isola L., Bahceci E., et al. Adult human mesenchymal stem cells added to corticosteroids therapy for the treatment of acute graft-versus-host disease. Biology of Blood and Marrow Transplantation 2009, 15:804-811.
32. Kikushige Y., Yoshimoto G., Miyamoto T., et al. Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival. Journal of Immunology 2008, 180:7358-7367.
33. Körbling M., Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: Does the source of hematopoietic stem cells matter?. Blood 2001, 98:2900-2908.
34. Knudtzon S. In vitro growth of granulocytic colonies from circulating cells in human cord blood. Blood 1974, 43:357-361.
35. Kukekov V.G., Laywell E.D., Suslov O., et al. Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Experimental Neurology 1999, 156:333-344.
36. Landry D.W., Zucker H.A. Embryonic death and the creation of human embryonic stem cells. Journal of Clinical Investigation 2004, 114:1184-1186.
37. Le Blanc K., Götherström C., Ringdén O., et al. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005, 79:1607-1614.
38. Lee A., Kessler J.D., Read T.A., et al. Isolation of neural stem cells from the postnatal cerebellum. Nature Neuroscience 2005, 8:723-729.
39. Li L., Xie T. Stem cell niche: Structure and function. Annual Review of Cell and Developmental Biology 2005, 21:605-631.
40. Manz M.G., Miyamoto T., Akashi K. Prospective Isolation of human clonogenic common myeloid progenitors. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:11872-11877.
41. Marx J.C., Gordon P.L., Horwitz E.M., et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:8932-8937.
42. Müller F.J., Snyder E.Y., Loring J.F. Gene therapy: Can neural stem cells deliver?. Nature Reviews Neuroscience 2006, 7:75-84.
43. Nait-Oumesmar B., Decker L., Lachapelle F., et al. Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. European Journal of Neuroscience 2008, 11:4357-4366.
44. Nakahara H., Dennis J.E., Bruder S.P., et al. In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Experimental Cell Research 1991, 195:492-503.
45. Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007, 110:3499-3506.
46. Park I.H., Arora N., Huo H., et al. Disease-specific induced pluripotent stem cells. Cell 2008, 134:877-886.
47. Park I.H., Zhao R., West J.A., et al. Reprogramming of human somatic cells to pluripotency by defined factors. Nature 2008, 451:141-146.
48. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
49. White Paper: Alternative Sources of Pluripotent Stem Cells 2005, President's Council on Bioethics, Presidernt's Council on Bioethics, Washington, DC.
50. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
51. Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255:1707-1710.
52. Schofield R. The relationship between the spleen colony-forming cell and the haematopoietic stem cell. Blood Cells 1978, 4:7-25.
53. Schwartz P.H., Bryant P.J., Fuja T.J., et al. Isolation and characterization of neural progenitor cells from post-mortem human cortex. Journal of Neuroscience Research 2003, 74:838-851.
54. Shen Q., Goderie S.K., Jin L., et al. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 2004, 304:1338-1340.
55. Simmons P.J., Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991, 78:55-62.
56. Taichman R.S., Emerson S.G. The role of osteoblasts in the hematopoietic microenvironment. Stem Cells 1998, 16:7-15.
57. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
58. Takahashi K., Tanabe K., Ohnuki M., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
59. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
60. Tuli R., Seghatoleslami M.R., Tuli S., et al. A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone. Molecular Biotechnology 2003, 23:37-49.
61. Varnum-Finney B., Xu L., Brashem-Stein C., et al. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nature Medicine 2000, 6:1278-1281.
62. Vierbuchen T., Ostermeier A., Pang Z.P., et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1041.
63. Warner-Schmidt J.L., Duman R.S. Hippocampal neurogenesis: Opposing effects of stress and antidepressant treatment. Hippocampus 2006, 16:239-249.
64. Wobus A.M., Boheler K.R. Embryonic stem cells: Prospects for developmental biology and cell therapy. Physiological Reviews 2005, 85:635-678.
65. Woltjen K., Michael I.P., Mohseni P., et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458:766-770.
66. Yahata T., Muguruma Y., Yumino S., et al. Quiescent human hematopoietic stem cells in the bone marrow niches organize the hierarchical structure of hematopoiesis. Stem Cells 2008, 28:3228-3236.
67. Yin A.H., Miraglia S., Zanjani E.D., et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997, 90:5002-5012.
68. Yin T., Li L. The stem cell niches in bone. Journal of Clinical Investigation 2006, 116:1195-1201.
69. Young K.M., Merson T.D., Sotthibundhu A., et al. p75 Neurotrophin receptor expression defines a population of BDNF-responsive neurogenic precursor cells. Journal of Neuroscience 2007, 27:5146-5155.
70. Yu J., Vodyanik M.A., Smuga-Otto K., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
71. Zuk P.A., Zhu M., Ashjian P., et al. Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell 2002, 13:4279-4295.
72. Allegrucci C., Young L.E. Differences between human embryonic stem cell lines. Human Reproduction Update 2007, 13:103-120.
73. Banin E., Obolensky A., Idelson M., et al. Retinal incorporation and differentiation of neural precursors derived from human embryonic stem cells. Stem Cells 2006, 24:246-257.
74. Carpenter M.K., Rosler E.S., Fisk G.J., et al. Properties of four human embryonic stem cell lines maintained in a feeder-free culture system. Developmental Dynamics: An Official Publication of the American Association of Anatomists 2004, 229:243-258.
75. D'Amour K.A., Agulnick A.D., Eliazer S., et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nature Biotechnology 2005, 23:1534-1541.
76. Da Cruz L., Chen F.K., Ahmado A., Greenwood J., Coffey P. RPE transplantation and its role in retinal disease. Progress in Retinal and Eye Research 2007, 26:598-635.
77. Hoffman L.M., Carpenter M.K. Characterization and culture of human embryonic stem cells. Nature Biotechnology 2005, 23:699-708.
78. Kehat I., Gepstein L. Derivation and properties of human embryonic stem cell-derived cardiomyocytes. Gene Therapy and Regulation 2002, 1:387-398.
79. Keirstead H.S., Nistor G., Bernal G., et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. Journal of Neuroscience 2005, 25:4694-4705.
80. Klimanskaya I., Chung Y., Becker S., et al. Human embryonic stem cell lines derived from single blastomeres. Nature 2006, 444:481-485.
81. Klimanskaya I., Hipp J., Rezai K.A., et al. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning and Stem Cells 2004, 6:217-245.
82. Kroon E., Martinson L.A., Ksdoya K., et al. Pancreatic endoderm derived from human embryonic stem cells generated glucose-responsive insulin-secreting cells in vivo. Nature Biotechnology 2008, 26:443-452.
83. Meyer J.S., Katz M.L., Maruniak J.A., Kirk M.D. Neural differentiation of mouse embryonic stem cells in vitro and after transplantation into eyes of mutant mice with rapid retinal degeneration. Brain Research 2004, 1014:131-144.
84. Meyer J.S., Katz M.L., Maruniak J.A., Kirk M.D. Embryonic stem cell-derived neural progenitors incorporate into degenerating retina and enhance survival of host photoreceptors. Stem Cells 2006, 24:274-283.
85. Rho J.Y., Yu K., Han J.S., et al. Transcriptional profiling of the developmentally important signalling pathways in human embryonic stem cells. Human Reproduction 2006, 21:405-412.
86. Rogers N.T., Hobson E., Pickering S., et al. Phospholipase Cζcauses Ca2+ oscillations and parthenogenetic activation of human oocytes. Reproduction 2004, 128:697-702.
87. Skottman H., Mikkola M., Lundin K., et al. Gene expression signatures of seven individual human embryonic stem cell lines. Stem Cells 2005, 23:1343-1356.
88. Zhang S.-C., Wernig M., Duncan I.D., et al. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nature Biotechnology 2001, 19:1129-1133.
89. Aasen T., Raya A., Barrero M.J., et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nature Biotechnology 2008, 26:1276-1284.
90. Agarwal S., Yuin-Han L., McLoughlin E.M., et al. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 2010, 464:292-296.
91. Bernstein B.E., Mikkelsen T.S., Xie X., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125:315-326.
92. Chen Y., Shi L., Zhang L., et al. The molecular mechanism governing the oncogenic potential of Sox2 in breast cancer. Journal of Biological Chemistry 2008, 283:17969-17978.
93. Chen Z.Y., He C.Y., Kay M.A. Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo. Human Gene Therapy 2005, 16:126-131.
94. Choi K.D., Yu J., Smuga-Otto K., et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 2009, 27:559-567.
95. Dimos J.T., Rodolfa K.T., Niakan K.K., et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008, 321:1218-1221.
96. Ebert A.D., Yu J., Rose F.F., et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457:277-280.
97. Fraser M.J., Ciszczon T., Elick T., Bauser C. Precise excision of TTAA-specific lepidopteran transposons piggyBac (IFP2) and tagalong (TFP3) from the baculovirus genome in cell lines from two species of Lepidoptera. Insect Molecular Biology 1996, 5:141-151.
98. Gertow K., Przyborski S., Loring J., et al. Isolation of human embryonic stem cell-derived teratomas for the assessment of pluripotency. Current Protocol in Stem Cell Biology U1.B4 2007, 10.1002/9780470151808.sc01b04s3.
99. Giorgetti A., Montserrat N., Rodriguez-Piza I., et al. Generation of induced pluripotent stem cells from human cord blood cells with only two factors: Oct4 and Sox2. Nature Protocols 2010, 5:811-820.
100. Greider C.W., Blackburn E.H. Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell 1985, 43:405-413.
101. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
102. Heng J.D., Feng B., Han J., et al. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell 2009, 6:167-174.
103. Hirami Y., Osakada F., Takahashi K., et al. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neuroscience Letters 2009, 458:126-131.
104. Hu B.Y., Weick J.P., Yu J., et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proceedings of National Academy of Sciences of the United States of America 2010, 107:4335-4340.
105. Jia F., Wilson K.D., Sun N., et al. A nonviral minicircle vector for deriving human iPS cells. Nature Methods 2010, 7:197-199.
106. Kehat I., Kenyagin-Karsenti D., Snir M., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. Journal of Clinical Investigation 2001, 108:407-414.
107. Kim D., Kim C.H., Moon J.I., et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4:472-476.
108. Kim J.B., Greber B., Araúzo-Bravo M.J., et al. Direct reprogramming of human neural stem cells by Oct4. Nature 2009, 461:649-653.
109. Lee S.H., Lumelsky N., Studer L., et al. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nature Biotechnology 2000, 18:675-679.
110. Lei H., Oh S.P., Okano M., et al. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development 1996, 122:3195-3205.
111. Li C., Zhou J., Shi G., et al. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Human Molecular Genetics 2009, 18:4340-4349.
112. Li W., Wang D., Qin J., et al. Generation of functional hepatocytes from mouse induced pluripotent stem cells. Journal of Cellular Physiology 2010, 222:492-501.
113. Li Y., Zhao H., Lan F., et al. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of Oct4/Sox2/Nanog. Cellular Reprogramming 2010, 12(3):237-247.
114. Lumelsky N., Blondel O., Laeng P., et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001, 292:1389-1394.
115. Maherali N., Sridharan R., Xie W., et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007, 1:55-70.
116. Narazaki G., Uosaki H., Teranishi M., et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008, 118:498-506.
117. Meissner A., Wernig M., Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nature Biotechnology 2007, 25:1177-1181.
118. Okita K., Nakagawa M., Hyenjong H., et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322:948-953.
119. Ponzielli R., Katz S., Barsyte-Lovejoy D., Penn L.Z. Cancer therapeutics: Targeting the dark side of Myc. European Journal of Cancer 2005, 41:2485-2501.
120. Rowland B.D., Peeper D.S. KLF4, p21 and context-dependent opposing forces in cancer. Nautre Reviews Cancer 2006, 6:11-23.
121. Shin S., Dalton S., Stice S. Human motor neuron differentiation from human embryonic stem cell. Stem Cells and Development 2005, 14:1-4.
122. Sun N., Panetta N.J., Gupta D.M., et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:15720-15725.
123. Svetlana N.R., Paramjeet K.R., Victoria L.B. In vitro differentiation of mouse embryonic stem cells into primitive blood vessels. Methods in Enzymology 2008, 443:103-117.
124. Tateishi K., He J., Taranova O., et al. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. Journal of Biological Chemistry 2008, 283:31601-31607.
125. Thompson S., Clarke A.R., Pow A.M., et al. Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryoni stem cells. Cell 1989, 56:313-321.
126. Trosko J.E. From adult stem cells to cancer stem cells: Oct-4 gene, cell-cell communication, and hormones during tumor promotion. Annals of the New York Academy of Sciences 2006, 1089:36-58.
127. Zhang D., Jiang W., Liu M., et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin producing cells. Cell Research 2009, 19:429-438.
128. Zhang J., Wilson G.F., Soerens A.G., et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circulation Research 2009, 104:30-41.
129. Zhao Y., Yin X., Qin H., et al. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 2008, 3:475-479.
130. Zhou W., Freed C.R. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 2009, 27:2667-2674.
131. Encinas J.M., Vaahtokari A., Enikolopov G. Fluoxetine targets early progenitor cells in the adult brain. Proceedings of the National Academy of Sciences 2006, 103:8233-8238.
132. Elkabetz Y., Panagiotakos G., Shamy G.A., et al. Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes and Development 2007, 22:152-165.
133. Malberg J.E., Duman R.S. Cell proliferation in adult hippocampus is decreased by inescapable stress: Reversal by fluoxetine treatment. Neuropsychopharmacology 2003, 28:1562-1571.
134. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. Journal of Neuroscience 2000, 20:9104-9110.
135. Maslov A.Y., Barone T.A., Plunkett R.J., Pruitt S.C. Neural stem cell detection, characterization, and age-related changes in the subventricular zone of mice. Journal of Neuroscience 2004, 24:1726-1733.
136. Mercier F., Kitasako J.T., Hatton G.I. Anatomy of the brain neurogenic zones revisited: Fractones and the fibroblast/macrophage network. Journal of Comparative Neurology 2002, 451:170-188.
137. Pevny L.H., Nicolis S.K. Sox2 roles in neural stem cells. International Journal of Biochemistry and Cell Biology 2010, 42:421-424.
138. Trounson A. New perspectives in human stem cell therapeutic research. BMC Medicine 2009, 7:29.
139. Wada K., Nakajima A., Katayama K., et al. Peroxisome proliferator-activated receptor γ-mediated regulation of neural stem cell proliferation and differentiation. Journal of Biological Chemistry 2006, 281:12673-12681.
140. Xu R., Wu C., Tao Y., et al. Nestin-positive cells in the spinal cord: A potential source of neural stem cells. Neuroscience 2008, 26:813-820.
141. Gordon P.L., Horwitz E.M., Prockop D.J., et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001, 97:1227-1231.
142. Horwitz E.M., Prockop D.J., Gordon P.L., et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nature Medicine 1999, 5:309-313.
143. Koç O.N., Day J., Nieder M., et al. Allogeneic mesenchymal stem cell infusion for treatment of Metachromatic Leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002, 30:215-222.
144. Onken J, Gallup D, Hanson J, et al. (2006) Successful outpatient treatment of refractory Crohn's disease using adult mesenchymal stem cells. Paper Presented at the American College of Gastroenterology Conference.
145. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infracted myocardium. Nature 2001, 410:701-705.
146. Pochampally R. Colony forming unit assays for MSCs. Methods in Molecular Biology 2008, 449:83-91.
147. Sato Y., Araki H., Kato J., et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005, 106:756-763.
148. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002, 106:1913-1918.
149. Wakitani S., Imoto K., Yamamoto T., et al. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis and Cartillage 2002, 10:199-206.
150. Bhardwaj G., Murdoch B., Wu D., et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nature Immunology 2001, 2:172-180.
151. Couban S., Simpson D.R., Barnett M.J., et al. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 2002, 100:1525-1531.
152. Cutler C., Antin J.H. Peripheral blood stem cells for allogeneic transplantation: A review. Stem Cells 2001, 19:108-117.
153. Edvardsson L., Dykes J., Olofsson T. Isolation and characterisation of human myeloid progenitor populations-TpoR as discriminator between common myeloid and egakaryocyte/erythroid progenitors. Experimental Hematology 2006, 34:599-609.
154. Ferrara J.L., Levine J.E., Reddy P., Holler E. Graft-versus-host disease. Lancet 2009, 373:1550-1561.
155. Fritsch G., Buchinger P., Printz D., et al. Rapid discrimination of early CD34+ myeloid progenitors using CD45-RA analysis. Blood 1993, 81:2301-2309.
156. Haspel R.L., Miller K.B. Hematopoietic stem cells: Sources matter. Current Stem Cell Research and Therapy 2008, 3:229-236.
157. - hematopoietic stem cells. Blood 1994, 83:1515-1526.
158. Hwang W.Y.K. Haematopoietic graft engineering. Annals, Academy of Medicine, Singapore 2004, 33:551-558.
159. Hwang W.Y.K., Ong S.Y. Allogeneic haematopoietic stem cell transplantation without a matched sibling donor: Current options and future potential. Annals, Academy of Medicine, Singapore 2009, 38:340-345.
160. Iwasaki H., Akashi K. Hematopoietic developmental pathways: On cellular basis. Nature Oncogene 2007, 26:6687-6696.
161. Karanu F.N., Murdoch B., Gallacher L., et al. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. Journal of Experimental Medicine 2000, 192:1365-1372.
162. Kondo M., Weissman I.L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997, 91:661-672.
163. Körbling M., Burke P., Braine H., et al. Successful engraftment of blood-derived normal hematopoietic stem cells in chronic myelogenous leukemia. Experimental Hematology 1981, 9:684-690.
164. Lee S.J., Klein J., Haagenson M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110:4576-4583.
165. Lorenz E., Uphoff E.D., Reid T.R., Shelton E. Modification of acute irradiation injury in mice and guinea pigs by bone marrow injection. Radiology 1951, 58:863-877.
166. Main J.M., Prehn R.T. Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow. Journal of the National Cancer Institute 1955, 15:1023-1029.
167. Pasquini M.C., Wang Z. Current use and outcome of hematopoietic stem cell transplantation: Part I - CIBMTR Summary Slides. Center for International Blood and Marrow Transplant Research Newsletter 2009, 15(1):7-11. [serial online].
168. Rafii S., Shapiro F., Pettengell R., et al. Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 1995, 86:3353-3363.
169. Rocha V., Labopin M., Sanz G., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. New England Journal of Medicine 2004, 351:2276-2285.
170. Sharma S., Gurudutta G.U., Satija N.K., et al. Stem cell c-KIT and HOXB4 genes: Critical roles and mechanisms in self-renewal, proliferation and differentiation. Stem Cells and Development 2006, 15:755-778.
171. Siminovitch L., McCulloch E.A., Till J.E. The distribution of colony-forming cells among spleen colonies. Journal of Cellular and Comparative Physiology 1963, 62:327-336.
172. Spitzer T.R. The expanding applications of non-myeloablative stem cell transplantation. Pediatric Transplantation 2003, 7:95-100.
173. Tabbara I.A., Zimmerman K., Morgan C., Nahleh Z. Allogeneic hematopoietic stem cell transplantation: Complications and results. Archives of Internal Medicine 2002, 162:1558-1566.
174. Taichman R.S., Emerson S.G. Human osteoblasts support hematopoiesis through the production of granulocyte-colony stimulating factor. Journal of Experimental Medicine 1994, 179:1677-1682.
175. Takahashi S., Ooi J., Tomonari A., et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adults patients with hematologic malignancies after myeloablative conditioning regimen. Blood 2007, 109:1322-1330.
176. Thomas E.D., Storb R. Technique for human marrow grafting. Blood 1970, 36:507-515.
177. Thomas E.D., Lochte H.L., Lu W.C., Ferrebee J.W. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. New England Journal of Medicine 1957, 257:491-496.
178. Thomas E.D., Lochte H.L., Cannon J.H., et al. Supralethal whole body irradiation and isologous marrow transplantation in man. Journal of Clinical Investigation 1959, 38:1709-1716.
179. Van Der Berg D.J., Sharma A.K., Bruno E., Hoffman R. Role of members of the Wnt gene family in human hematopoiesis. Blood 1998, 92:3189-3202.
180. Wilson A., Trumpp A. Bone-marrow haematopoietic stem-cell niches. Nature Immunology 2006, 6:93-106.
181. Wright D.E., Cheshier S.H., Wagners A.J., et al. Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after Mphase of the cell cycle. Blood 2001, 97:2278-2285.
182. Scientists see progress in FDA stem cell trial approval. Sciencedaily 2009, International Society for Stem Cell Research, accessed November 2010. http://www.sciencedaily.com.
183. Vergano D. Stem cells approved to treat 'orphan' disease. Advanced Cell Technology 2010, accessed November 2010. http://www.advancedcell.com.
184. Douglass B. Advanced Cell Technology's studies to support phase 1 multicenter trial of patients with Stargardt's Macular Dystrophy demonstrate excellent safety profile. Advanced Cell Technology 2010, accessed November 2010. http://www.advancedcell.com.
185. ReNeuron receives final regulatory approval to commence landmark stroke clinical trial in UK ReNeuron, accessed November 2010. http://www.reneuron.com.
186. StemCells Inc. Plans to Advance to Second Clinical Trial in Batten Disease StemCells Inc, accessed November 2010. http://www.stemcellsinc.com.
187. ® and microfracture in patients with knee articular cartilage injury or defect accessed November 2010. http://clinicaltrials.gov.
188. Osiris T. Extended evaluation of Prochymal[tm] adult human stem cells for treatment-resistant moderate-to-severe Crohn's disease accessed November 2010. http://clinicaltrials.gov.
189. Repeated infusions of mesenchymal stromal cells in children with Osteogenesis Imperfecta (STOD3) Children's Hospital of Philadelphia, accessed November 2010. http://clinicaltrials.gov.
190. Physiological changes: Stem cells - Mesenchymal stem cell numbers - age, aging, differences Medicine Encyclopedia, accessed November 2010. http://medicine.jrank.org.